Children getting more psychiatric prescriptions from PCPs than specialists
Primary care providers (PCPs) play a more substantial role in pediatric mental health than do psychologists, psychiatrists and social workers, researchers have found. Children and youth are also receiving psychotropic medications at a higher rate than those who receive care from mental health professionals. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - October 25, 2015 Category: Psychiatry Tags: What's New in Research Source Type: research

Cognitive depression prevention for at‐risk teens found effective
Can adolescent depression be prevented? Possibly, given the fact that if adolescents' parents have a history of depression, they are at greater risk for the disorder — and for functional impairment. That means these teens can be selectively targeted for an intervention. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - October 25, 2015 Category: Psychiatry Tags: Depression Source Type: research

Risperidone treatment for irritability in ASD produces good outcomes, balancing weight gain
While risperidone has been shown to be effective for short‐term (8‐week and 6‐month) management of severe irritability and aggression in children and adolescents with autism, less is known about long‐term effects. Researchers looked at tolerability, safety, and therapeutic benefits of long‐term use of the medication and found that the risks — weight gain, enuresis, and increased appetite — were balanced by the benefits. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - September 24, 2015 Category: Psychiatry Tags: Autism Spectrum Disorders Source Type: research

FDA approves OxyContin for certain pediatric patients
On August 13, the federal Food and Drug Administration approved OxyContin for the treatment of pain in certain pediatric patients — those whose pain is “severe enough to require daily, around‐the‐clock, long‐term opioid treatment and for which alternative treatment options are inadequate,” the FDA said in announcing the approval. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - September 23, 2015 Category: Psychiatry Tags: From the FDA Source Type: research

Research Roundup
High school students vaping cannabis with e‐cigarettes (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - September 23, 2015 Category: Psychiatry Tags: Research Roundup Source Type: research

Genetic predisposition, not cannabis use, causes reduced amygdala volume
Cannabis use has been associated with changes in brain structure. Studying siblings who did not use cannabis can help determine whether these changes are causal or due to the effects of genetics and family environment on brain structure and cannabis use. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - September 23, 2015 Category: Psychiatry Tags: What's New in Research Source Type: research

Atomoxetine and parent training improve ADHD symptoms and noncompliance in children with ASD
Children with autism spectrum disorder (ASD) who also have attention‐deficit hyperactivity disorder (ADHD) are also likely to have noncompliance — ignoring, refusing, defying, or arguing. Stimulants, while they work well for typically developing children with ADHD, have lower response rates in children with ASD. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - September 23, 2015 Category: Psychiatry Tags: What's New in Research Source Type: research

Phenotype for reduced brain connectivity linked to childhood‐onset schizophrenia
Brain connectivity structural abnormalities have been seen in patients with schizophrenia. By looking at changes longitudinally and analyzing genetic risk in sibling studies, researchers can help find out what progressive changes are associated with schizophrenia. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - September 23, 2015 Category: Psychiatry Tags: Schizophrenia Source Type: research

Cortical thickness decreases in ADHD youths; stimulant treatment, age no effect
Changes in cortical thickness (CT) have been associated with attention‐deficit hyperactivity disorder (ADHD). Studies have suggested that these changes could be ameliorated with stimulant treatment. However, findings have been inconsistent. Researchers wanted to look at differences in CT in adolescents and young adults with and without ADHD. They also looked at whether differences were related to age and to stimulant treatment. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - August 26, 2015 Category: Psychiatry Tags: ADHD Source Type: research

FDA approves Rexulti to treat schizophrenia and as an add‐on to an antidepressant to treat major depressive disorder
On July 10, the U.S. Food and Drug Administration approved Rexulti (brexpiprazole) tablets to treat adults with schizophrenia and as an add‐on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD). (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - August 25, 2015 Category: Psychiatry Tags: From the FDA Source Type: research

Research Roundup
Many genetic markers likely accountable for antidepressant response Problems linked to teen marijuana use College‐age students don't know where to find help for opioid overdoses: Survey (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - August 25, 2015 Category: Psychiatry Tags: Research Roundup Source Type: research

Study shows assessing temper loss in preschool years could predict psychopathology
Irritability, which is easily apparent in the preschool years, doesn't necessarily lead to psychopathology. However, it is present in various forms of mental illness, and because it falls along a spectrum, is a precursor to mental illness. The problem for researchers is to be able to use a dimensional, rather than a diagnostic, approach to tell when a young child needs clinical intervention. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - August 25, 2015 Category: Psychiatry Tags: What's New in Research Source Type: research

Study finds lack of psychotherapy and no mental health diagnosis in most teen antipsychotic use
Antipsychotic prescribing increased for adolescents and young adults during the 2006–2010 time period, with most probably being used to treat behavioral problems like aggression that normal teens age out of, according to a new study looking at trends and patterns of antipsychotic prescribing among young people. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - August 25, 2015 Category: Psychiatry Tags: What's New in Research Source Type: research

ACLU charges sheriff with ADA violations in handcuffing of children with ADHD
Two elementary school children in Kentucky with attention‐deficit hyperactivity disorder (ADHD) who were allegedly restrained for behaviors related to their disability by a school sheriff are the plaintiffs in a federal lawsuit citing a violation of their civil rights under the Americans with Disabilities Act (ADA). (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - August 25, 2015 Category: Psychiatry Tags: Civil Rights Source Type: research

Psychiatric problems in childhood lead to problems transitioning to adulthood
Most psychiatric disorders are first diagnosed in childhood, unlike most chronic physical health problems. Therefore, the disorders and their sequelae can affect people into adulthood and throughout their entire lives. In particular, the rare but highly impairing disorders such as schizophrenia and pervasive developmental disorders cause a significant burden, but so do more common emotional and behavioral disorders, many of which may fade as the child ages into adulthood. (Source: The Brown University Child and Adolescent Psychopharmacology Update)
Source: The Brown University Child and Adolescent Psychopharmacology Update - July 29, 2015 Category: Psychiatry Tags: Common Disorders Source Type: research